Study shows women quickly catch up to men in terms of cardiovascular risk; underscores the need for increased awareness and screening.
Telix to expand US footprint with IsoTherapeutics acquisition
Share this article The acquisition is expected to enhance Telix’s ability to innovate and scale-up manufacturing, especially for clinical trials. Credit: Alexander Raths / Shutterstock.com.